Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    Marrow transplantation for the treatment of chronic myelogenous leukemia.

    Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, et al.

    Ann Intern Med. 1986 Feb;104(2):155-63.PMID: 3511810 [PubMed - indexed for MEDLINE]Related articles

    2.

    Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.

    McGlave P, Arthur D, Haake R, Hurd D, Miller W, Vercellotti G, Weisdorf D, Kim T, Ramsay N, Kersey J.

    J Clin Oncol. 1987 Jul;5(7):1033-40.PMID: 3298558 [PubMed - indexed for MEDLINE]Related articles

    3.

    Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.

    Woolfrey AE, Gooley TA, Sievers EL, Milner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anasetti C, Bryant E, Appelbaum FR, Sanders JE.

    Blood. 1998 Nov 15;92(10):3546-56.PMID: 9808546 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.

    Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM.

    Blood. 1995 Nov 1;86(9):3590-7. Review.PMID: 7579468 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.

    Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, et al.

    Blood. 1994 Apr 1;83(7):1980-7.PMID: 8142664 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Bone marrow transplantation in patients aged 45 years and older.

    Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum FR, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, et al.

    Blood. 1986 Mar;67(3):770-6.PMID: 3511986 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Bone marrow transplantation for chronic granulocytic leukemia.

    Lehn P, Devergie A, Benbunan M, Lemercier N, Raffoux C, Rabian C, Vilmer E, Azogui O, Irti T, Gluckman E.

    J Natl Cancer Inst. 1986 Jun;76(6):1301-5.PMID: 3520072 [PubMed - indexed for MEDLINE]Related articles

    8.

    Allogeneic marrow transplantation for chronic granulocytic leukemia.

    Fefer A, Clift RA, Thomas ED.

    J Natl Cancer Inst. 1986 Jun;76(6):1295-9.PMID: 3520071 [PubMed - indexed for MEDLINE]Related articles

    9.

    Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.

    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.

    Bone Marrow Transplant. 1996 May;17(5):685-9.PMID: 8733682 [PubMed - indexed for MEDLINE]Related articles

    10.

    Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

    Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, et al.

    Ann Intern Med. 1988 Jun;108(6):806-14.PMID: 3285744 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.

    Devergie A, Reiffers J, Vernant JP, Herve P, Guyotat D, Maraninchi D, Rio B, Michallet M, Jouet JP, Milpied N, et al.

    Bone Marrow Transplant. 1990 Jun;5(6):379-86. Erratum in: Bone Marrow Transplant 1990 Oct;6(4):following 282. PMID: 2088319 [PubMed - indexed for MEDLINE]Related articles

    12.

    Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

    Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF, Weiss M, Cohen A, Nekolla E, Kolb HJ.

    Ann Intern Med. 1997 Feb 1;126(3):184-92.PMID: 9027268 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

    Arcese W, Goldman JM, D'Arcangelo E, Schattenberg A, Nardi A, Apperley JF, Frassoni F, Aversa F, Prentice HG, Ljungman P, et al.

    Blood. 1993 Nov 15;82(10):3211-9.PMID: 7693042 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

    Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, Shore TB, Walker IR, Browett P, Messner HA, Panzarella T, Lipton JH; Canadian Bone Marrow Transplant Group.

    Blood. 2002 Sep 1;100(5):1525-31.PMID: 12176866 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

    Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR.

    Blood. 1995 Nov 15;86(10):3987-96.PMID: 7579370 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.

    Greinix HT, Keil F, Brugger SA, Reiter E, Linkesch W, Lechner K, Schneider B, Dieckmann KU, Fischer G, Schwarzinger I, Haas O, Hinterberger W, Mannhalter C, Geissler K, Hocker P, Jager U, Kalhs P.

    Ann Hematol. 1996 Feb;72(2):53-9.PMID: 8597607 [PubMed - indexed for MEDLINE]Related articles

    17.

    A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.

    Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift RA, Storb R, Buckner CD, Appelbaum FR, Hansen JA, Sullivan KM.

    Blood. 1995 Sep 1;86(5):2028-32.PMID: 7655031 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients]

    Tomás JF, Peñarrubia MJ, García JA, Figuera A, Gómez-García de Soria V, Steegmann JL, Arranz R, Cámara R, Gabriel R, Vázquez L, et al.

    Med Clin (Barc). 1995 Nov 11;105(16):605-11. Spanish. PMID: 8523939 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

    Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P.

    Blood. 1996 Jul 15;88(2):714-20.PMID: 8695820 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

    Ringdén O, Labopin M, Gorin NC, Schmitz N, Schaefer UW, Prentice HG, Bergmann L, Jouet JP, Mandelli F, Blaise D, Fouillard L, Frassoni F; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.

    Br J Haematol. 2000 Dec;111(4):1130-7.PMID: 11167752 [PubMed - indexed for MEDLINE]Related articles